Review



dnam 1 fc  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    R&D Systems dnam 1 fc
    (A) Display of ULBP1 and CD155 on CombiCells detected by mAbs and NKG2D-Fc, and <t>DNAM-1-Fc,</t> respectively. (B&C) KIR2DL1+ and KIR2DL1-NK-cell degranulation (CD107a upregulation) in response to ULBP1, CD155, and HLA-C*05:01 displayed on CombiCells. (C) Three types of HLA-C*05:01 were tested, all containing P2 (IIDKSGSTV); wild-type, open and dipeptide exchanged. Data from three independent experiments with NK cells from separate donors are shown.
    Dnam 1 Fc, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/dnam 1 fc/product/R&D Systems
    Average 94 stars, based on 4 article reviews
    dnam 1 fc - by Bioz Stars, 2026-04
    94/100 stars

    Images

    1) Product Images from "Using peptide-exchange systems to interrogate peptide-specific KIR binding to HLA Class I"

    Article Title: Using peptide-exchange systems to interrogate peptide-specific KIR binding to HLA Class I

    Journal: bioRxiv

    doi: 10.64898/2026.03.03.708729

    (A) Display of ULBP1 and CD155 on CombiCells detected by mAbs and NKG2D-Fc, and DNAM-1-Fc, respectively. (B&C) KIR2DL1+ and KIR2DL1-NK-cell degranulation (CD107a upregulation) in response to ULBP1, CD155, and HLA-C*05:01 displayed on CombiCells. (C) Three types of HLA-C*05:01 were tested, all containing P2 (IIDKSGSTV); wild-type, open and dipeptide exchanged. Data from three independent experiments with NK cells from separate donors are shown.
    Figure Legend Snippet: (A) Display of ULBP1 and CD155 on CombiCells detected by mAbs and NKG2D-Fc, and DNAM-1-Fc, respectively. (B&C) KIR2DL1+ and KIR2DL1-NK-cell degranulation (CD107a upregulation) in response to ULBP1, CD155, and HLA-C*05:01 displayed on CombiCells. (C) Three types of HLA-C*05:01 were tested, all containing P2 (IIDKSGSTV); wild-type, open and dipeptide exchanged. Data from three independent experiments with NK cells from separate donors are shown.

    Techniques Used:



    Similar Products

    fitc dnam 1  (Miltenyi Biotec)
    94
    Miltenyi Biotec fitc dnam 1
    Fitc Dnam 1, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/fitc dnam 1/product/Miltenyi Biotec
    Average 94 stars, based on 1 article reviews
    fitc dnam 1 - by Bioz Stars, 2026-04
    94/100 stars
    		  Buy from Supplier
    dnam 1 fc  (R&D Systems)
    94
    R&D Systems dnam 1 fc
    (A) Display of ULBP1 and CD155 on CombiCells detected by mAbs and NKG2D-Fc, and <t>DNAM-1-Fc,</t> respectively. (B&C) KIR2DL1+ and KIR2DL1-NK-cell degranulation (CD107a upregulation) in response to ULBP1, CD155, and HLA-C*05:01 displayed on CombiCells. (C) Three types of HLA-C*05:01 were tested, all containing P2 (IIDKSGSTV); wild-type, open and dipeptide exchanged. Data from three independent experiments with NK cells from separate donors are shown.
    Dnam 1 Fc, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/dnam 1 fc/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    dnam 1 fc - by Bioz Stars, 2026-04
    94/100 stars
    		  Buy from Supplier
    cd226  (R&D Systems)
    94
    R&D Systems cd226
    (A) Display of ULBP1 and CD155 on CombiCells detected by mAbs and NKG2D-Fc, and <t>DNAM-1-Fc,</t> respectively. (B&C) KIR2DL1+ and KIR2DL1-NK-cell degranulation (CD107a upregulation) in response to ULBP1, CD155, and HLA-C*05:01 displayed on CombiCells. (C) Three types of HLA-C*05:01 were tested, all containing P2 (IIDKSGSTV); wild-type, open and dipeptide exchanged. Data from three independent experiments with NK cells from separate donors are shown.
    Cd226, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd226/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    cd226 - by Bioz Stars, 2026-04
    94/100 stars
    		  Buy from Supplier
    dx11  (fluidigm)
    93
    fluidigm dx11
    (A) Display of ULBP1 and CD155 on CombiCells detected by mAbs and NKG2D-Fc, and <t>DNAM-1-Fc,</t> respectively. (B&C) KIR2DL1+ and KIR2DL1-NK-cell degranulation (CD107a upregulation) in response to ULBP1, CD155, and HLA-C*05:01 displayed on CombiCells. (C) Three types of HLA-C*05:01 were tested, all containing P2 (IIDKSGSTV); wild-type, open and dipeptide exchanged. Data from three independent experiments with NK cells from separate donors are shown.
    Dx11, supplied by fluidigm, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/dx11/product/fluidigm
    Average 93 stars, based on 1 article reviews
    dx11 - by Bioz Stars, 2026-04
    93/100 stars
    		  Buy from Supplier
    3171013b  (fluidigm)
    93
    fluidigm 3171013b
    (A) Display of ULBP1 and CD155 on CombiCells detected by mAbs and NKG2D-Fc, and <t>DNAM-1-Fc,</t> respectively. (B&C) KIR2DL1+ and KIR2DL1-NK-cell degranulation (CD107a upregulation) in response to ULBP1, CD155, and HLA-C*05:01 displayed on CombiCells. (C) Three types of HLA-C*05:01 were tested, all containing P2 (IIDKSGSTV); wild-type, open and dipeptide exchanged. Data from three independent experiments with NK cells from separate donors are shown.
    3171013b, supplied by fluidigm, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/3171013b/product/fluidigm
    Average 93 stars, based on 1 article reviews
    3171013b - by Bioz Stars, 2026-04
    93/100 stars
    		  Buy from Supplier
    cd226 dnam 1  (fluidigm)
    93
    fluidigm cd226 dnam 1
    (A) Display of ULBP1 and CD155 on CombiCells detected by mAbs and NKG2D-Fc, and <t>DNAM-1-Fc,</t> respectively. (B&C) KIR2DL1+ and KIR2DL1-NK-cell degranulation (CD107a upregulation) in response to ULBP1, CD155, and HLA-C*05:01 displayed on CombiCells. (C) Three types of HLA-C*05:01 were tested, all containing P2 (IIDKSGSTV); wild-type, open and dipeptide exchanged. Data from three independent experiments with NK cells from separate donors are shown.
    Cd226 Dnam 1, supplied by fluidigm, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd226 dnam 1/product/fluidigm
    Average 93 stars, based on 1 article reviews
    cd226 dnam 1 - by Bioz Stars, 2026-04
    93/100 stars
    		  Buy from Supplier
    anti cd226  (Cell Signaling Technology Inc)
    94
    Cell Signaling Technology Inc anti cd226
    (A) Display of ULBP1 and CD155 on CombiCells detected by mAbs and NKG2D-Fc, and <t>DNAM-1-Fc,</t> respectively. (B&C) KIR2DL1+ and KIR2DL1-NK-cell degranulation (CD107a upregulation) in response to ULBP1, CD155, and HLA-C*05:01 displayed on CombiCells. (C) Three types of HLA-C*05:01 were tested, all containing P2 (IIDKSGSTV); wild-type, open and dipeptide exchanged. Data from three independent experiments with NK cells from separate donors are shown.
    Anti Cd226, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti cd226/product/Cell Signaling Technology Inc
    Average 94 stars, based on 1 article reviews
    anti cd226 - by Bioz Stars, 2026-04
    94/100 stars
    		  Buy from Supplier
    anti pd 1  (Cell Signaling Technology Inc)
    94
    Cell Signaling Technology Inc anti pd 1
    (A) Display of ULBP1 and CD155 on CombiCells detected by mAbs and NKG2D-Fc, and <t>DNAM-1-Fc,</t> respectively. (B&C) KIR2DL1+ and KIR2DL1-NK-cell degranulation (CD107a upregulation) in response to ULBP1, CD155, and HLA-C*05:01 displayed on CombiCells. (C) Three types of HLA-C*05:01 were tested, all containing P2 (IIDKSGSTV); wild-type, open and dipeptide exchanged. Data from three independent experiments with NK cells from separate donors are shown.
    Anti Pd 1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti pd 1/product/Cell Signaling Technology Inc
    Average 94 stars, based on 1 article reviews
    anti pd 1 - by Bioz Stars, 2026-04
    94/100 stars
    		  Buy from Supplier
    dnam 1  (Miltenyi Biotec)
    94
    Miltenyi Biotec dnam 1
    (A) Display of ULBP1 and CD155 on CombiCells detected by mAbs and NKG2D-Fc, and <t>DNAM-1-Fc,</t> respectively. (B&C) KIR2DL1+ and KIR2DL1-NK-cell degranulation (CD107a upregulation) in response to ULBP1, CD155, and HLA-C*05:01 displayed on CombiCells. (C) Three types of HLA-C*05:01 were tested, all containing P2 (IIDKSGSTV); wild-type, open and dipeptide exchanged. Data from three independent experiments with NK cells from separate donors are shown.
    Dnam 1, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/dnam 1/product/Miltenyi Biotec
    Average 94 stars, based on 1 article reviews
    dnam 1 - by Bioz Stars, 2026-04
    94/100 stars
    		  Buy from Supplier

    Image Search Results


    (A) Display of ULBP1 and CD155 on CombiCells detected by mAbs and NKG2D-Fc, and DNAM-1-Fc, respectively. (B&C) KIR2DL1+ and KIR2DL1-NK-cell degranulation (CD107a upregulation) in response to ULBP1, CD155, and HLA-C*05:01 displayed on CombiCells. (C) Three types of HLA-C*05:01 were tested, all containing P2 (IIDKSGSTV); wild-type, open and dipeptide exchanged. Data from three independent experiments with NK cells from separate donors are shown.

    Journal: bioRxiv

    Article Title: Using peptide-exchange systems to interrogate peptide-specific KIR binding to HLA Class I

    doi: 10.64898/2026.03.03.708729

    Figure Lengend Snippet: (A) Display of ULBP1 and CD155 on CombiCells detected by mAbs and NKG2D-Fc, and DNAM-1-Fc, respectively. (B&C) KIR2DL1+ and KIR2DL1-NK-cell degranulation (CD107a upregulation) in response to ULBP1, CD155, and HLA-C*05:01 displayed on CombiCells. (C) Three types of HLA-C*05:01 were tested, all containing P2 (IIDKSGSTV); wild-type, open and dipeptide exchanged. Data from three independent experiments with NK cells from separate donors are shown.

    Article Snippet: For binding assays, APC-conjugated Fc fusion protein (NKG2D-Fc (R&D Systems, Cat. No: 1299-NK) or DNAM-1-Fc (R&D Systems, Cat. No: # 666-DN) or KIR-Fc (R&D Systems, KIR2DL1-Fc (Cat. No: 1844-KR-050), KIR2DL3-Fc (Cat. No: 2014-KR-050), KIR2DS4-Fc (Cat. No: 1847-KR-050) (3.6 μg mL -1 ) was added at 25 μL per well and incubated for 30 min at 4 °C in the dark.

    Techniques: